Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI

Journal Article · · J. Clin. Invest.; (United States)
DOI:https://doi.org/10.1172/JCI111361· OSTI ID:6626770
Binding of /sup 125/I-Factor XIa to platelets required the presence of high molecular weight kininogen, was enhanced when platelets were stimulated with thrombin, and reached a plateau after 4-6 min of incubation at 37 degrees C. Factor XIa binding was specific: 50- to 100-fold molar excesses of unlabeled Factor XIa prevented binding, whereas Factor XI, prekallikrein, Factor XIIa, and prothrombin did not. When washed erythrocytes, added at concentrations calculated to provide an equivalent surface area to platelets, were incubated with Factor XIa, only a low level of nonspecific, nonsaturable binding was detected. Factor XIa binding to platelets was partially reversible and was saturable at concentrations of added Factor XIa of 0.2-0.4 microgram/ml (1.25-2.5 microM). The number of Factor XIa binding sites on activated platelets was estimated to be 225 per platelet (range, 110-450). We conclude that specific, high affinity, saturable binding sites for Factor XIa are present on activated platelets, are distinct from those previously demonstrated for Factor XI, and require the presence of high molecular weight kininogen.
Research Organization:
Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania
OSTI ID:
6626770
Journal Information:
J. Clin. Invest.; (United States), Journal Name: J. Clin. Invest.; (United States) Vol. 73:6; ISSN JCINA
Country of Publication:
United States
Language:
English